H. Lundbeck A/S
- Country
- π©π°Denmark
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 5.6K
- Market Cap
- -
- Website
- http://www.lundbeck.com
Safety and Tolerability of Lu AF95245 in Healthy Young Men
- Conditions
- Interventions
- First Posted Date
- 2019-12-16
- Last Posted Date
- 2020-05-12
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 18
- Registration Number
- NCT04199585
- Locations
- π³π±
QPS Netherlands BV, Groningen, Netherlands
Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman
- First Posted Date
- 2019-12-13
- Last Posted Date
- 2020-09-23
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 96
- Registration Number
- NCT04197349
- Locations
- π¦πΊ
Nucleus Network Pty Ltd, Melbourne, Australia
Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD)
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2020-12-09
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 6
- Registration Number
- NCT04175132
- Locations
- πΈπͺ
Karolinska Institutet, Stockholm, Sweden
A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine
- First Posted Date
- 2019-11-05
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 485
- Registration Number
- NCT04152083
- Locations
- πΊπΈ
Aventiv Research - Columbus, Columbus, Ohio, United States
πΊπΈNeuro-Behavioral Clinical Research Inc, North Canton, Ohio, United States
πΊπΈExcell research Inc, Oceanside, California, United States
Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease
- First Posted Date
- 2019-11-04
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 86
- Registration Number
- NCT04149860
- Locations
- πΊπΈ
Clinilabs, Inc., New York, New York, United States
πΊπΈPAREXEL International, Glendale, California, United States
πΊπΈPrinceton Medical Institute, Princeton, New Jersey, United States
A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2020-04-17
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 33
- Registration Number
- NCT04104503
- Locations
- π¬π§
Quotient, Nottingham, United Kingdom
Study Investigating the Safety and Tolerability of Lu AF88434 in Healthy Young Men
- First Posted Date
- 2019-09-09
- Last Posted Date
- 2021-02-24
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 68
- Registration Number
- NCT04082325
- Locations
- π³π±
QPS, Groningen, Netherlands
What the Body Does to Foliglurax in Healthy Volunteers
- First Posted Date
- 2019-07-01
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 6
- Registration Number
- NCT04002895
- Locations
- π¬π§
GB1050 Covance, Leeds, United Kingdom
Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms
- First Posted Date
- 2019-04-26
- Last Posted Date
- 2020-09-23
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 96
- Registration Number
- NCT03929497
- Locations
- π§π¬
First Department for men with acute mental diseases-NPH Sv. Ivan Rilski (BG0010), Novi Iskar, Bulgaria
πͺπͺOU Jaanson & Laane (EE0002), Tartu, Estonia
ππΊDr Mathe es Tarsa Bt (HU0001), Kalocsa, Hungary
A Study Investigating Formulations of Vortioxetine Applied Under the Tongue in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2019-03-21
- Last Posted Date
- 2019-08-01
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 16
- Registration Number
- NCT03884491
- Locations
- π¬π§
Quotient Sciences Ltd, Nottingham, United Kingdom